SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:prod.swepub.kib.ki.se:144476996"
 

Search: onr:"swepub:oai:prod.swepub.kib.ki.se:144476996" > Impact of deviation...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00002955naa a2200421 4500
001oai:prod.swepub.kib.ki.se:144476996
003SwePub
008240701s2020 | |||||||||||000 ||eng|
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1444769962 URI
024a https://doi.org/10.1038/s41598-020-58007-52 DOI
040 a (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Ho, PJ4 aut
2451 0a Impact of deviation from guideline recommended treatment on breast cancer survival in Asia
264 c 2020-01-28
264 1b Springer Science and Business Media LLC,c 2020
520 a Breast cancer survival has improved with significant progress in treatment and disease management. However, compliance with treatment varies. Treatment guidelines for older patients are unclear. We aim to identify predictors of noncompliance with recommended therapy in a large breast cancer population and assess the impact of noncompliance on survival. Our study included 19,241 non-metastatic female breast cancer patients, of whom 3,158 (16%) died within 10 years post-diagnosis (median survival = 5.8 years). We studied the association between treatment noncompliance and factors with logistic regression, and the impact of treatment noncompliance on survival with a flexible parametric survival model framework. The highest proportion of noncompliance was observed for chemotherapy (18%). Predictors of noncompliance with chemotherapy, radiotherapy and endocrine therapy included age, tumor size, nodal involvement and subtype (except radiotherapy). Factors associated with not receiving surgery included age and subtype. Treatment noncompliance was associated with worse overall survival for surgery (HR: 2.26 [1.80–2.83]), chemotherapy (1.25 [1.11–1.41]), radiotherapy (2.28 [1.94–2.69]) and endocrine therapy (1.70 [1.41–2.04]). Worse survival was similarly observed in older patients for whom guidelines generally do not apply. Our results highlight the importance of following appropriate treatment as recommended by current guidelines. Older patients may benefit from similar recommendations.
700a Ow, SGW4 aut
700a Sim, YR4 aut
700a Liu, J4 aut
700a Lim, SH4 aut
700a Tan, EY4 aut
700a Tan, SM4 aut
700a Lee, SC4 aut
700a Tan, VKM4 aut
700a Yap, YS4 aut
700a Chay, WY4 aut
700a Tan, BKT4 aut
700a Wong, FY4 aut
700a Li, JM4 aut
700a Hartman, M4 aut
773t Scientific reportsd : Springer Science and Business Media LLCg 10:1, s. 1330-q 10:1<1330-x 2045-2322
856u https://www.nature.com/articles/s41598-020-58007-5.pdf
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:144476996
8564 8u https://doi.org/10.1038/s41598-020-58007-5

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view